Genmab A/S (OTCMKTS:GNMSF) Share Price Passes Below Two Hundred Day Moving Average of $370.17

Shares of Genmab A/S (OTCMKTS:GNMSFGet Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $370.17 and traded as low as $315.00. Genmab A/S shares last traded at $324.07, with a volume of 821 shares traded.

Genmab A/S Stock Down 0.5 %

The firm’s 50 day simple moving average is $329.62 and its 200-day simple moving average is $369.51.

Genmab A/S (OTCMKTS:GNMSFGet Free Report) last announced its earnings results on Tuesday, November 7th. The company reported $4.72 earnings per share (EPS) for the quarter. Genmab A/S had a net margin of 25.54% and a return on equity of 15.03%. The firm had revenue of $692.80 million for the quarter.

About Genmab A/S

(Get Free Report)

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.

Recommended Stories

Receive News & Ratings for Genmab A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genmab A/S and related companies with's FREE daily email newsletter.